Related Experiment Video
Updated: Jun 8, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Factors affecting prognosis in myelofibrosis
1Hematology I - Bone Marrow Transplantation Center, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, University of Milan Via Francesco Sforza 35, 20122 Milan Italy.
Prognostic scoring systems are crucial for primary myelofibrosis (PMF) patients. Recent advances in treatments like JAK2 inhibitors and stem cell transplants necessitate accurate tools for personalized therapy selection.
Area of Science:
- Hematology
- Oncology
- Stem Cell Transplantation
Background:
- Primary myelofibrosis (PMF) exhibits significant clinical heterogeneity.
- Accurate prognostic scoring is vital due to evolving treatment landscapes.
Purpose of the Study:
- To summarize current knowledge on prognostic factors in PMF.
- To highlight recent advancements in PMF patient stratification and treatment selection.
Main Methods:
- Review of existing literature on PMF prognosis.
- Analysis of recent therapeutic developments, including JAK2 inhibitors and stem cell transplantation.
Main Results:
- Numerous factors influencing PMF prognosis have been identified.
- New therapeutic strategies necessitate refined prognostic models.
Conclusions:
- Simple, accurate scoring systems are increasingly critical for guiding PMF treatment decisions.
- Ongoing research aims to improve patient selection for therapies like stem cell transplantation and JAK2 inhibitors.
Related Concept Videos
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Differentiation of Common Myeloid Progenitor Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...

